Document Type
Article
Publication Date
1996
Publication Title
Public Health Reports
Volume
111
First page number:
335
Last page number:
341
Abstract
In the United States, nearly all new human immunodeficiency virus (HIV) infections in children are acquired through perinatal (mother-to-infant) transmission. Each year, approximately 7000 infants are born to HIV-infected women in the United States.1 Without intervention, an estimated 15-30% of these infants would become infected.2 In 1994, results of the AIDS Clinical Trial Group (ACTG) Protocol 076 showed that treatment of infected pregnant women and their infants with zidovudine (ZDV) reduced the rate of perinatal HIV transmission from 25% to 8%.3,4 Following these findings, the Public Health Service (PHS) issued recommendations for ZDV therapy to prevent perinatal HIV transmission5 and for HIV counseling and voluntary testing of pregnant women.6
Keywords
AIDS (Disease) – Prevention; AIDS (Disease) in pregnancy; HIV infections – Prevention; HIV infections – Transmission; HIV-positive children
Disciplines
Analytical, Diagnostic and Therapeutic Techniques and Equipment | Immune System Diseases | Maternal and Child Health | Obstetrics and Gynecology | Public Health | Virus Diseases
Language
English
Repository Citation
Gorsky, R. D.,
Farnham, P. G.,
Straus, W. L.,
Caldwell, B.,
Holtgrave, D. R.,
Simonds, R. J.,
Rogers, M. F.,
Guinan, M.
(1996).
Preventing Perinatal Transmission of HIV Costs and Effectiveness of a Recommended Intervention.
Public Health Reports, 111
335-341.
https://digitalscholarship.unlv.edu/community_health_sciences_fac_articles/48
Included in
Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons, Immune System Diseases Commons, Maternal and Child Health Commons, Obstetrics and Gynecology Commons, Virus Diseases Commons